Karl-Ludwig Laugwitz

Showing 1-19 of 19 articles

Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents: a pooled analysis of individual patient data

Cassese S, Katagiri Y, Byrne R, Brugaletta S, Alfonso F, Räber L, Maeng M, Iñiguez A, Kretov E, Onuma Y, Joner M, Sabate M, Laugwitz K, Windecker S, Kastrati A, Serruys P

March 20, 2020 | 10.4244/EIJ-D-18-01080

Peripheral interventions

Incidence and predictors of stent thrombosis after endovascular revascularisation of the superficial femoral artery

Bradaric C, Koppara T, Müller A, Haller B, Ott I, Cassese S, Fusaro M, Kastrati A, Laugwitz K, Ibrahim T

December 20, 2019 | 10.4244/EIJ-D-19-00187

Coronary interventions

Enhanced platelet inhibition by clopidogrel and risk of bleeding in patients requiring oral anticoagulation after drug-eluting stent implantation

Goedel A, Fiedler K, Mehilli J, Bernlochner I, von Olshausen G, Mayer K, Schüpke S, Hoppmann P, Sibbing D, Maeng M, Massberg S, Schunkert H, Laugwitz K, Kastrati A, Sarafoff N

October 18, 2019 | 10.4244/EIJ-D-18-00995

Coronary interventions

Sex and long-term outcomes after implantation of the Absorb bioresorbable vascular scaffold for treatment of coronary artery disease

Baquet M, Hoppmann P, Grundmann D, Schmidt W, Kufner S, Theiss H, Brunner S, Wiebe J, Eickhoff M, Jochheim D, Byrne R, Laugwitz K, Schunkert H, Massberg S, Kastrati A, Mehilli J

September 20, 2019 | 10.4244/EIJ-D-18-00603

Coronary interventions

Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials

Cassese S, Ndrepepa G, Byrne R, Kufner S, Lahmann AL, Mankerious N, Xhepa E, Laugwitz K, Schunkert H, Fusaro M, Kastrati A, Joner M

June 20, 2018 | 10.4244/EIJ-D-18-00024

Changes in high-sensitivity troponin after drug-coated balloon angioplasty for drug-eluting stent restenosis

Colleran R, Harada Y, Kufner S, Giacoppo D, Joner M, Cassese S, Ibrahim T, Laugwitz K, Kastrati A, Byrne R

October 20, 2017 | 10.4244/EIJ-D-16-00939

Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials

Cassese S, Ndrepepa G, Byrne R, Kufner S, Xhepa E, De Waha A, Rheude T, Colleran R, Giacoppo D, Harada Y, Laugwitz K, Schunkert H, Fusaro M, Kastrati A

October 20, 2017 | 10.4244/EIJ-D-16-00871

Peripheral interventions

Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis

Cassese S, Ndrepepa G, Kufner S, Byrne R, Giacoppo D, Ott I, Laugwitz K, Schunkert H, Kastrati A, Fusaro M

July 20, 2017 | 10.4244/EIJ-D-16-00735

Interventions for hypertension

Drug-eluting stents versus bare metal stents for the prevention of restenosis in patients with renovascular disease

Bradaric C, Eser K, Preuss S, Dommasch M, Wustrow I, Langwieser N, Haller B, Ott I, Fusaro M, Heemann U, Laugwitz K, Kastrati A, Ibrahim T

June 2, 2017 | 10.4244/EIJ-D-16-00697

Coronary interventions

Angiographic and clinical outcomes of patients treated with drug-coated balloon angioplasty for in-stent restenosis after coronary bifurcation stenting with a two-stent technique

Harada Y, Colleran R, Pinieck S, Giacoppo D, Michel J, Kufner S, Cassese S, Joner M, Ibrahim T, Laugwitz K, Kastrati A, Byrne R

April 20, 2017 | 10.4244/EIJ-D-16-00226

Coronary interventions

Impact of stent size on angiographic and clinical outcomes after implantation of everolimus-eluting bioresorbable scaffolds in daily practice: insights from the ISAR-ABSORB registry

Wiebe J, Hoppmann P, Kufner S, Harada Y, Colleran R, Michel J, Giacoppo D, Schneider S, Cassese S, Ibrahim T, Schunkert H, Laugwitz K, Kastrati A, Byrne R

June 10, 2016 | 10.4244/EIJY16M05_03

Coronary interventions

Five-year outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease: final results from the ISAR-TEST 4 randomised trial

Kufner S, Byrne R, Valeskini M, Schulz S, Ibrahim T, Hoppmann P, Schneider S, Laugwitz K, Schunkert H, Kastrati A

March 18, 2016 | 10.4244/EIJY14M11_02

Coronary interventions

Impact of bivalirudin on post-procedural epicardial blood flow, risk of stent thrombosis and mortality after percutaneous coronary intervention

Fiedler A, Ndrepepa G, Schulz S, Floh S, Hoppmann P, Kufner S, Bernlochner I, Byrne R, Schunkert H, Laugwitz K, Kastrati A

February 12, 2016 | 10.4244/EIJV11I11A249

Bivalirudin versus heparin in patients treated with percutaneous coronary intervention: a meta-analysis of randomised trials

Cassese S, Byrne R, Laugwitz K, Schunkert H, Berger P, Kastrati A

June 19, 2015 | 10.4244/EIJY14M08_01

How should I treat a complex left subclavian artery stenosis involving the vertebral artery in a patient with subclavian steal syndrome and left internal mammary artery bypass graft?

Ibrahim T, Langwieser N, Dommasch M, Wildgruber M, Laugwitz K

March 20, 2015 | 10.4244/EIJV10I11A236

Rationale and design of a randomised clinical trial comparing vascular closure device and manual compression to achieve haemostasis after diagnostic coronary angiography: the Instrumental Sealing of ARterial puncture site – CLOSURE device versus manual compression (ISAR-CLOSURE) trial

Xhepa E, Byrne R, Schulz S, Helde S, Gewalt S, Cassese S, Linhardt M, Ibrahim T, Mehilli J, Hoppe K, Grupp K, Kufner S, Bottiger C, Hoppmann P, Burgdorf C, Fusaro M, Ott I, Schneider S, Hengstenberg C, Schunkert H, Laugwitz K, Kastrati A

June 20, 2014 | 10.4244/EIJV10I2A33

Prognostic value of bleeding after percutaneous coronary intervention in patients with diabetes

Ndrepepa G, Schulz S, Neumann F, Laugwitz K, Richardt G, Byrne R, Pohler A, Kastrati A, Pache J

May 20, 2014 | 10.4244/EIJV10I1A14

One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-ST-segment elevation myocardial infarction: updated results from the ISAR-REACT 4 trial

Schulz S, Kastrati A, Ferenc M, Massberg S, Birkmeier K, Laugwitz K, Kufner S, Gick M, Dommasch M, Schühlen H, Schömig A, Berger P, Mehilli J, Neumann F

August 23, 2013 | 10.4244/EIJV9I4A71

Time does not heal all wounds: very late stent thrombosis eight years after implantation of a sirolimus-eluting stent due to positive remodelling, saccular evaginations and marked vascular inflammation

Orban M, Joner M, Riegger J, Steigerwald K, Tada T, Ibrahim T, Laugwitz K, Byrne R, Kastrati A, Massberg S

July 26, 2013 | 10.4244/EIJV9I3A66

1

Latest news

Focus on emerging physiology indices, TAVI, sizing with abnormal aortic cusps, a megaregistry of complex PCIs and more…

Tetralogy of Fallot with acquired double right ventricular outflow tract

September 18, 2020

Ahead of print: Leaflex Study

September 23, 2020

Integrating physiology in OCT

September 23, 2020

VOYAGER PAD, PARTNER 2A, ISCHEMIA and much more

(The Trials book is supported by Biotronik)

August 28, 2020

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Steady-state hyperaemia

September 18, 2020

This Week's JAA's: Biograde Study, Advances in valvular heart interventions...

September 22, 2020

Valvular disease